These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 10728356)
1. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Javadov SA; Lim KH; Kerr PM; Suleiman MS; Angelini GD; Halestrap AP Cardiovasc Res; 2000 Jan; 45(2):360-9. PubMed ID: 10728356 [TBL] [Abstract][Full Text] [Related]
2. Protection of ischaemic-reperfused rat heart by dimethylamiloride is associated with inhibition of mitochondrial permeability transition. Prendes MG; Torresín E; González M; Fernández MA; Perazzo JC; Savino EA; Varela A Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):201-6. PubMed ID: 17941897 [TBL] [Abstract][Full Text] [Related]
3. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Halestrap AP; Kerr PM; Javadov S; Woodfield KY Biochim Biophys Acta; 1998 Aug; 1366(1-2):79-94. PubMed ID: 9714750 [TBL] [Abstract][Full Text] [Related]
4. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. Javadov SA; Clarke S; Das M; Griffiths EJ; Lim KH; Halestrap AP J Physiol; 2003 Jun; 549(Pt 2):513-24. PubMed ID: 12692185 [TBL] [Abstract][Full Text] [Related]
6. Temperature preconditioning of isolated rat hearts--a potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mitochondrial permeability transition pore. Khaliulin I; Clarke SJ; Lin H; Parker J; Suleiman MS; Halestrap AP J Physiol; 2007 Jun; 581(Pt 3):1147-61. PubMed ID: 17395631 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of mitochondrial remodeling by cyclosporine A preserves myocardial performance in a neonatal rabbit model of cardioplegic arrest. Oka N; Wang L; Mi W; Caldarone CA J Thorac Cardiovasc Surg; 2008 Mar; 135(3):585-93. PubMed ID: 18329475 [TBL] [Abstract][Full Text] [Related]
8. Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia. Dobsak P; Courderot-Masuyer C; Zeller M; Vergely C; Laubriet A; Assem M; Eicher JC; Teyssier JR; Wolf JE; Rochette L J Cardiovasc Pharmacol; 1999 Nov; 34(5):651-9. PubMed ID: 10547080 [TBL] [Abstract][Full Text] [Related]
9. Ischemia time impacts on respiratory chain functions and Ca Leistner M; Sommer S; Kanofsky P; Leyh R; Sommer SP J Cardiothorac Surg; 2019 May; 14(1):92. PubMed ID: 31088484 [TBL] [Abstract][Full Text] [Related]
10. NHE-1 inhibition-induced cardioprotection against ischaemia/reperfusion is associated with attenuation of the mitochondrial permeability transition. Javadov S; Choi A; Rajapurohitam V; Zeidan A; Basnakian AG; Karmazyn M Cardiovasc Res; 2008 Jan; 77(2):416-24. PubMed ID: 18006455 [TBL] [Abstract][Full Text] [Related]
11. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Liu YN; Zhou ZM; Chen P Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891 [TBL] [Abstract][Full Text] [Related]
12. Intralipid, a clinically safe compound, protects the heart against ischemia-reperfusion injury more efficiently than cyclosporine-A. Li J; Iorga A; Sharma S; Youn JY; Partow-Navid R; Umar S; Cai H; Rahman S; Eghbali M Anesthesiology; 2012 Oct; 117(4):836-46. PubMed ID: 22814384 [TBL] [Abstract][Full Text] [Related]
14. Effects of potassium channel modulation during global ischaemia in isolated rat heart with and without cardioplegia. Galiñanes M; Shattock MJ; Hearse DJ Cardiovasc Res; 1992 Nov; 26(11):1063-8. PubMed ID: 1291083 [TBL] [Abstract][Full Text] [Related]
15. Interactions between preischemic hypothermia and cardioplegic solutions in the neonatal lamb heart. Aoki M; Nomura F; Mayer JE J Thorac Cardiovasc Surg; 1994 Mar; 107(3):822-8. PubMed ID: 8127111 [TBL] [Abstract][Full Text] [Related]
16. Cardioprotection with esmolol cardioplegia: efficacy as a blood-based solution. Fujii M; Chambers DJ Eur J Cardiothorac Surg; 2013 Mar; 43(3):619-27. PubMed ID: 22715477 [TBL] [Abstract][Full Text] [Related]
17. Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury. Halestrap AP; Connern CP; Griffiths EJ; Kerr PM Mol Cell Biochem; 1997 Sep; 174(1-2):167-72. PubMed ID: 9309682 [TBL] [Abstract][Full Text] [Related]
18. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent. Bessho R; Chambers DJ J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806 [TBL] [Abstract][Full Text] [Related]
19. Vascular and contractile function and tissue metabolites after prolonged hypothermic ischaemia and reperfusion: comparison of single- versus multi-dose infusions with two cardioplegic solutions in blood-perfused neonatal pig hearts. Galiñanes M; Saldanha C; Kato H; Elliott MJ; de Leval MR; Hearse DJ J Mol Cell Cardiol; 1995 Sep; 27(9):1915-30. PubMed ID: 8523452 [TBL] [Abstract][Full Text] [Related]
20. Effect of edaravone, a novel free radical scavenger, supplemented to cardioplegia on myocardial function after cardioplegic arrest: in vitro study of isolated rat heart. Yamazaki K; Miwa S; Toyokuni S; Nemoto S; Oriyanhan W; Takaba K; Saji Y; Marui A; Nishina T; Ikeda T; Komeda M Heart Vessels; 2009 May; 24(3):228-35. PubMed ID: 19466525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]